6.
Fisher D, Princic N, Miller-Wilson L, Wilson K, Fendrick A, Limburg P
. Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk. JAMA Netw Open. 2021; 4(9):e2122269.
PMC: 8414191.
DOI: 10.1001/jamanetworkopen.2021.22269.
View
7.
Yang J, McDowell A, Kim E, Seo H, Lee W, Moon C
. Development of a colorectal cancer diagnostic model and dietary risk assessment through gut microbiome analysis. Exp Mol Med. 2019; 51(10):1-15.
PMC: 6802675.
DOI: 10.1038/s12276-019-0313-4.
View
8.
Burnett B, Zhou S, Brophy S, Davies P, Ellis P, Kennedy J
. Machine Learning in Colorectal Cancer Risk Prediction from Routinely Collected Data: A Review. Diagnostics (Basel). 2023; 13(2).
PMC: 9858109.
DOI: 10.3390/diagnostics13020301.
View
9.
Atkin W, Edwards R, Kralj-Hans I, Wooldrage K, Hart A, Northover J
. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010; 375(9726):1624-33.
DOI: 10.1016/S0140-6736(10)60551-X.
View
10.
Kinar Y, Kalkstein N, Akiva P, Levin B, Half E, Goldshtein I
. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc. 2016; 23(5):879-90.
PMC: 4997037.
DOI: 10.1093/jamia/ocv195.
View
11.
Sawicki T, Ruszkowska M, Danielewicz A, Niedzwiedzka E, Arlukowicz T, Przybylowicz K
. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers (Basel). 2021; 13(9).
PMC: 8122718.
DOI: 10.3390/cancers13092025.
View
12.
Xu W, Mesa-Eguiagaray I, Kirkpatrick T, Devlin J, Brogan S, Turner P
. Development and Validation of Risk Prediction Models for Colorectal Cancer in Patients with Symptoms. J Pers Med. 2023; 13(7).
PMC: 10381199.
DOI: 10.3390/jpm13071065.
View
13.
Davidson K, Barry M, Mangione C, Cabana M, Caughey A, Davis E
. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021; 325(19):1965-1977.
DOI: 10.1001/jama.2021.6238.
View
14.
Xi Y, Xu P
. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021; 14(10):101174.
PMC: 8273208.
DOI: 10.1016/j.tranon.2021.101174.
View
15.
DeLong E, Delong D, Clarke-Pearson D
. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44(3):837-45.
View
16.
Vulcan A, Manjer J, Ohlsson B
. High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study. BMC Cancer. 2017; 17(1):842.
PMC: 5727949.
DOI: 10.1186/s12885-017-3874-4.
View
17.
Aleksandrova K, Reichmann R, Kaaks R, Jenab M, Bueno-de-Mesquita H, Dahm C
. Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score. BMC Med. 2021; 19(1):1.
PMC: 7780676.
DOI: 10.1186/s12916-020-01826-0.
View
18.
Jones R, Devers K, Kuzel A, Woolf S
. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med. 2010; 38(5):508-16.
PMC: 2946825.
DOI: 10.1016/j.amepre.2010.01.021.
View
18.
Han S, Shin H, Lee J, Liu Z, Rabadan R, Lee J
. Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target. Exp Mol Med. 2019; 51(12):1-11.
PMC: 6897967.
DOI: 10.1038/s12276-019-0351-y.
View
19.
Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz M
. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021; 384(15):1412-1423.
PMC: 7944975.
DOI: 10.1056/NEJMoa2101765.
View